AstraZeneca is trading up 3.08% at $160.62 on October 14 as healthcare stocks advance, with the sector up 1.64%. - UnitedHealth’s earnings beat and raised full-year outlook have boosted sentiment across healthcare. - Deutsche Bank upgraded AstraZeneca from sell to hold, and Nordea upgraded it to buy; available reports do not directly attribute the intraday gain to either call.